374 related articles for article (PubMed ID: 36358647)
1. Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma
Kashani E; Vassella E
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358647
[TBL] [Abstract][Full Text] [Related]
2. Protein Phosphatase 2A in the Regulation of Wnt Signaling, Stem Cells, and Cancer.
Thompson JJ; Williams CS
Genes (Basel); 2018 Feb; 9(3):. PubMed ID: 29495399
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.
Janssens V; Goris J
Biochem J; 2001 Feb; 353(Pt 3):417-39. PubMed ID: 11171037
[TBL] [Abstract][Full Text] [Related]
4. Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes.
Adams DG; Coffee RL; Zhang H; Pelech S; Strack S; Wadzinski BE
J Biol Chem; 2005 Dec; 280(52):42644-54. PubMed ID: 16239230
[TBL] [Abstract][Full Text] [Related]
5. The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors.
Cucinotta L; Filippone A; Casili G; Lanza M; Bova V; Capra AP; Giuffrida R; Colarossi C; Sciacca D; Paterniti I; Cuzzocrea S; Campolo M; Esposito E
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555359
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells.
Nifoussi SK; Ratcliffe NR; Ornstein DL; Kasof G; Strack S; Craig RW
J Biol Chem; 2014 Aug; 289(32):21950-9. PubMed ID: 24939844
[TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 2A interacts with Chk2 and regulates phosphorylation at Thr-68 after cisplatin treatment of human ovarian cancer cells.
Liang X; Reed E; Yu JJ
Int J Mol Med; 2006 May; 17(5):703-8. PubMed ID: 16596250
[TBL] [Abstract][Full Text] [Related]
8. PP2A Counterbalances Phosphorylation of pRB and Mitotic Proteins by Multiple CDKs: Potential Implications for PP2A Disruption in Cancer.
Kurimchak A; Graña X
Genes Cancer; 2012 Nov; 3(11-12):739-48. PubMed ID: 23634261
[TBL] [Abstract][Full Text] [Related]
9. The protein phosphatase 2A regulatory subunit B56γ mediates suppression of T cell receptor (TCR)-induced nuclear factor-κB (NF-κB) activity.
Breuer R; Becker MS; Brechmann M; Mock T; Arnold R; Krammer PH
J Biol Chem; 2014 May; 289(21):14996-5004. PubMed ID: 24719332
[TBL] [Abstract][Full Text] [Related]
10. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt.
Van Kanegan MJ; Adams DG; Wadzinski BE; Strack S
J Biol Chem; 2005 Oct; 280(43):36029-36. PubMed ID: 16129692
[TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase 2A: who shall regulate the regulator?
Goldberg Y
Biochem Pharmacol; 1999 Feb; 57(4):321-8. PubMed ID: 9933020
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma.
Maggio D; Ho WS; Breese R; Walbridge S; Wang H; Cui J; Heiss JD; Gilbert MR; Kovach JS; Lu RO; Zhuang Z
J Neurooncol; 2020 Jun; 148(2):231-244. PubMed ID: 32342332
[TBL] [Abstract][Full Text] [Related]
13. Identification of PP2A complexes and pathways involved in cell transformation.
Sablina AA; Hector M; Colpaert N; Hahn WC
Cancer Res; 2010 Dec; 70(24):10474-84. PubMed ID: 21159657
[TBL] [Abstract][Full Text] [Related]
14. PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer.
Fowle H; Zhao Z; Graña X
Adv Cancer Res; 2019; 144():55-93. PubMed ID: 31349904
[TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
[TBL] [Abstract][Full Text] [Related]
16. LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential.
Hong CS; Ho W; Zhang C; Yang C; Elder JB; Zhuang Z
Cancer Biol Ther; 2015; 16(6):821-33. PubMed ID: 25897893
[TBL] [Abstract][Full Text] [Related]
17. Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.
Nematullah M; Hoda MN; Khan F
Mol Neurobiol; 2018 Feb; 55(2):1750-1761. PubMed ID: 28224476
[TBL] [Abstract][Full Text] [Related]
18. Targeting PP2A for cancer therapeutic modulation.
Ronk H; Rosenblum JS; Kung T; Zhuang Z
Cancer Biol Med; 2022 Nov; 19(10):1428-39. PubMed ID: 36342229
[TBL] [Abstract][Full Text] [Related]
19. β-Adrenergic regulation of cardiac type 2A protein phosphatase through phosphorylation of regulatory subunit B56δ at S573.
Ranieri A; Kemp E; Burgoyne JR; Avkiran M
J Mol Cell Cardiol; 2018 Feb; 115():20-31. PubMed ID: 29294329
[TBL] [Abstract][Full Text] [Related]
20. Biased holoenzyme assembly of protein phosphatase 2A (PP2A): From cancer to small molecules.
Haanen TJ; O'Connor CM; Narla G
J Biol Chem; 2022 Dec; 298(12):102656. PubMed ID: 36328247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
